Myo-Inositol vs NMN for blood sugar: which has better evidence?
A tie on evidence grade for blood sugar (Myo-Inositol Grade B vs NMN Grade —). For blood sugar, Myo-Inositol has the stronger evidence grade.
Platform evidence comparison
These existing platform assessments are separate from the source-reported findings below. They do not represent a direct trial comparing these treatments.
| Myo-Inositol | NMN | |
|---|---|---|
| Grade | grade B | studied, no effect |
| Certainty | moderate | low |
| Effect | improves insulin sensitivity and ovulatory function in PCOS in multiple RCTs | Review of 8 human RCTs (342 mainly non-diabetic middle-age/older adults, 14 days to 12 weeks, 250-2000 mg/day): NMN supplementation showed no significant benefit on fasting glucose, fasting insulin, HbA1c, insulin resistance (HOMA-IR), or lipid profile. Short-term NMN supplementation did not meaningfully improve glucose control in this population. |
| Studied dose | 2–4 g/day myo-inositol | 250-2000 mg/day, 14 days to 12 weeks in the reviewed trials |
| Population | women with PCOS / insulin resistance | middle-age/older adults, mainly non-diabetic |
| Safety | 0 modeled interaction(s) | 0 modeled interaction(s) |
Grade B / moderate: probably helps, and new studies are unlikely to reverse this — but could shrink the effect size.
Direct comparison evidence
There are no direct RCTs in our corpus comparing Myo-Inositol and NMN head-to-head for blood sugar. What we present above is an indirect comparison: each side's own trials, contrasted. This is standard practice for supplement comparisons — dose, population, and outcome-instrument differences between the two evidence bases add uncertainty on top of each side's own grade.
Can you take both?
No modeled interaction between Myo-Inositol and NMN in our corpus. Absence of a recorded interaction is not proof of additive benefit — combined-effect trials are usually absent for supplement pairs, so treat "stack" claims skeptically.
Decision guidance
- If certainty matters most — choose whichever side carries the higher certainty rating at a similar grade.
- If you're on medications — check each side's interaction pages before deciding; safety differences dominate small evidence-grade gaps.
- If your population is under-studied — the smaller-effect side with better population evidence often wins over the higher-grade side studied in a different demographic.
- If cost matters — form and dose page differences (Myo-Inositol vs NMN) can invert the practical winner.
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 12 months (Grade A/B) — next review by . Methodology v1.
Re-review cadence: every 12 months (Grade A/B) · next scheduled by · methodology v1.
Frequently asked
Which has stronger evidence: Myo-Inositol or NMN for blood sugar?
Myo-Inositol carries Grade B at moderate certainty; NMN carries Grade — at low. The stronger evidence points to a tie, subject to the caveat that direct head-to-head trials are usually absent for supplement pairings.
Can I take Myo-Inositol and NMN together?
No modeled interaction between Myo-Inositol and NMN; combining is not documented to be problematic, but combined-effect trials are also absent, so treat additive benefit claims skeptically.
Have Myo-Inositol and NMN been compared head-to-head?
Direct RCTs comparing the two for blood sugar are uncommon. This page contrasts each side's own trial evidence — that is an indirect comparison, which introduces confounds from population and dose differences. See the direct-comparison block above.
What decides between Myo-Inositol and NMN for me?
Read the decision guidance below — the split usually comes down to population fit, interaction risk with your other medications, and how much certainty you want behind the recommendation.
Related
Cite this page
Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.
Plain-text citation
Substrate. Myo-Inositol vs NMN for blood sugar. https://evidencebased.info/compare/inositol-vs-nmn-for-blood-sugar. Updated 2026-07-14.
BibTeX
@misc{substrate_olvsnmnforbloodsugar,
author = {Substrate editorial},
title = {Myo-Inositol vs NMN for blood sugar},
year = {2026},
url = {https://evidencebased.info/compare/inositol-vs-nmn-for-blood-sugar},
note = {evidencebased.info}
}